Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany; European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) partner site Heidelberg/Mannheim, Mannheim, Germany.
Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany.
Am J Cardiol. 2023 Oct 15;205:141-149. doi: 10.1016/j.amjcard.2023.07.008. Epub 2023 Aug 18.
Atrial fibrillation (AF) is associated with increased risk of mortality in various clinical conditions. However, the prognostic role of preexisting and new-onset AF in critically ill patients, such as patients with septic or cardiogenic shock remains unclear. This study investigates the prognostic impact of preexisting and new-onset AF on 30-day all-cause mortality in patients with septic or cardiogenic shock. Consecutive patients with sepsis, or septic or cardiogenic shock were enrolled in 2 prospective, monocentric registries from 2019 to 2021. Statistical analyses included Kaplan-Meier, multivariable logistic, and Cox proportional regression analyses. In total, 644 patients were included (cardiogenic shock: n = 273; sepsis/septic shock: n = 361). The prevalence of AF was 41% (29% with preexisting AF, 12% with new-onset AF). Within the entire study cohort, neither preexisting AF (log-rank p = 0.542; hazard ratio [HR] 1.075, 95% confidence interval [CI] 0.848 to 1.363, p = 0.551) nor new-onset AF (log-rank p = 0.782, HR = 0.957, 95% CI 0.683 to 1.340, p = 0.797) were associated with 30-day all-cause mortality compared with non-AF. In patients with AF, ventricular rates >120 beats/min compared with ≤120 beats/min were shown to increase the risk of reaching the primary end point in AF patients with cardiogenic shock (log-rank p = 0.006, HR 1.886, 95% CI 1.164 to 3.057, p = 0.010). Furthermore, logistic regression analyses suggested increased age was the only predictor of new-onset AF (odds ratio 1.042, 95% CI 1.018 to 1.066, p = 0.001). In conclusion, neither the presence of preexisting AF nor the occurrence of new-onset AF was associated with the risk of 30-day all-cause mortality in consecutive patients admitted with cardiogenic shock.
心房颤动(AF)与各种临床情况下的死亡率增加相关。然而,在危重病患者(如感染性或心源性休克患者)中,预先存在的和新发的 AF 的预后作用仍不清楚。本研究调查了预先存在的和新发的 AF 对感染性或心源性休克患者 30 天全因死亡率的预后影响。连续纳入了 2019 年至 2021 年期间来自 2 个前瞻性、单中心登记处的感染性休克或感染性或心源性休克患者。统计分析包括 Kaplan-Meier、多变量逻辑和 Cox 比例回归分析。共纳入 644 例患者(心源性休克:n=273;感染性休克/感染性休克:n=361)。AF 的患病率为 41%(29%为预先存在的 AF,12%为新发 AF)。在整个研究队列中,预先存在的 AF(log-rank p=0.542;风险比[HR]1.075,95%置信区间[CI]0.848 至 1.363,p=0.551)或新发 AF(log-rank p=0.782,HR=0.957,95%CI 0.683 至 1.340,p=0.797)均与非 AF 患者相比,与 30 天全因死亡率无关。在 AF 患者中,与心室率≤120 次/分相比,心室率>120 次/分与心源性休克患者的主要终点增加相关(log-rank p=0.006,HR 1.886,95%CI 1.164 至 3.057,p=0.010)。此外,逻辑回归分析表明,年龄增加是新发 AF 的唯一预测因素(比值比 1.042,95%CI 1.018 至 1.066,p=0.001)。总之,在连续因心源性休克入院的患者中,预先存在的 AF 的存在或新发 AF 的发生均与 30 天全因死亡率的风险无关。